Overall, a good operating performance with 9m sales and EBITDA up by 11% and 15% respectively. It was able to manage its margins better than some of its peers as it is a solutions rather than just products provider which allows it to have flexible pricing. Management expects FY21 EBITDA at €5.25bn which is 7% above our current estimate. Hence, we will revise our estimates upwards which will lead to a positive revision to our target price.
23 Nov 2021
9m 21: faring better on the costs front
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
9m 21: faring better on the costs front
CRH public limited company (CRH:LON) | 6,247 -874.6 (-0.2%) | Mkt Cap: 43,165m
- Published:
23 Nov 2021 -
Author:
Sejal Varshney -
Pages:
3
Overall, a good operating performance with 9m sales and EBITDA up by 11% and 15% respectively. It was able to manage its margins better than some of its peers as it is a solutions rather than just products provider which allows it to have flexible pricing. Management expects FY21 EBITDA at €5.25bn which is 7% above our current estimate. Hence, we will revise our estimates upwards which will lead to a positive revision to our target price.